Interv Akut Kardiol. 2016;15(1):33-36 | DOI: 10.36290/kar.2016.006
Catheter-based left atrial appendage occlusion guided by intracardiac echocardiography
- Klinika kardiologie IKEM, Praha
Thrombosis of the left atrial appendage in atrial fibrillation is the leading cause of cardioembolic events. In patients with a history of
bleeding complications of anticoagulant therapy, the possible management of this condition is to occlude the left atrial appendage
and to discontinue anticoagulation. Catheter-based occlusion with dedicated occluders is one of potential ways of accomplishing this.
This paper presents our experience with left atrial appendage occlusion using the AmuletTM system guided by intracardiac ultrasound.
Keywords: left atrial appendage, catheter-based occlusion, intracardiac ultrasound
Published: February 1, 2016 Show citation
References
- January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Thou PJ, Tracy CM, Yancy CW. ACC/AHA TaskForce Members. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation. 2014; 130: e199-e267.
Go to original source... 
Go to PubMed... - Manning WJ. Atrial fibrillation, transesophageal echo, electrica lcardioversion, and anticoagulation. ClinCardiol. 1995; 18(58): 114.
- Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Eur Heart J. 2012; 33(21): 2719-2747. Go to original source... Go to PubMed...
- Sievert H, Lesh MD, Trepels T, et al. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation - early clinical experience. Circulation 2002; 105: 1887-1889. Go to original source... Go to PubMed...
- Meier B, Palacios I, Windecker S, Rotter M, Cao QL, Keane D, et al. Transcatheter left atrial appendage occlusion with Amplatzer devices to obviateanti coagulation in patients with atrial fibrillation. Catheter Cardiovasc Interv 2003; 60: 417-422. Go to original source... Go to PubMed...
- Šťásek J, Bis J, Vavera Z, Vojáček J, Dušek J, et al. Perkutánní eliminace ouška levé srdeční síně v prevenci systémové embolizace. Interv Akut Kardiol 2011; 10(5-6): 219-222.
- Klein AL, Grimm RA, Murray RD, Apperson-Hansen C, Asinger RW, Black IW, Davidoff R, Erbel R, Halperin JL, Orsinelli DA, Porter TR, Stoddard MF; Assessment of Cardioversion Using Transesophageal Echocardiography Investigators. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med 2001; 344: 1411-1420. Go to original source... Go to PubMed...
- Cox JL. Cardiac surgery for arrhythmias. J Cardiovasc Electrophysiol 2004; 15: 250-262. Go to original source... Go to PubMed...
- US Food and Drug Administration. WATCHMAN LAA closure technology: P130013, March 13, 2015.
- Centers for Medicareand Medicaid Services. Proposed decision memo for percutaneous left atrial appendage (LAA) closure therapy (CAG-00445N). November 10, 2015.
- Aldhoon B, Wichterle D, Peichl P, Čihák R, Kautzner J. Complications of catheter ablation for atrial fibrillation in a high-volume centre with the use of intracardiac echocardiography. Europace 2013; 15(1): 24-32. Go to original source... Go to PubMed...